What intramuscular ceftriaxone dose is appropriate for a 3‑month‑old infant weighing 7.3 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Intramuscular Dosing for a 3-Month-Old Infant (7.3 kg)

For a 3-month-old infant weighing 7.3 kg, administer ceftriaxone 50–75 mg/kg/day intramuscularly once daily (365–548 mg/day), with the specific dose determined by infection severity and type.

Standard Pediatric Dosing Algorithm

Non-Meningeal Infections (Most Common)

  • For skin/soft tissue infections, pneumonia, sepsis, or other serious infections: administer 50–75 mg/kg/day given once daily or divided every 12 hours, with a maximum of 2 grams daily 1, 2.
  • For this 7.3 kg infant: the calculated dose is 365–548 mg/day (50–75 mg/kg × 7.3 kg) 1.
  • Practical dosing: round to 400–500 mg IM once daily for ease of administration 1.

Meningitis or CNS Infections

  • For bacterial meningitis: the initial dose is 100 mg/kg/day (not to exceed 4 grams), which can be given once daily or divided every 12 hours 1, 2.
  • For this 7.3 kg infant with meningitis: administer 730 mg/day (100 mg/kg × 7.3 kg), typically divided as 365 mg every 12 hours 1, 2.

Acute Otitis Media (Single-Dose Regimen)

  • For treatment-refractory acute otitis media: a single IM dose of 50 mg/kg (maximum 1 gram) is recommended 2.
  • For this 7.3 kg infant: administer 365 mg IM as a single dose 2.

Age-Specific Considerations for Young Infants

Neonatal Dosing (If <28 Days Old)

  • The FDA label specifies that neonates >7 days old and >2000 g should receive 50–75 mg/kg/day every 24 hours 1.
  • Critical contraindication: ceftriaxone is contraindicated in neonates ≤28 days who require calcium-containing IV solutions due to precipitation risk 2.
  • Hyperbilirubinemia warning: ceftriaxone should not be used in hyperbilirubinemic neonates due to risk of bilirubin encephalopathy 1, 2.

Post-Neonatal Period (>28 Days, Which Applies Here)

  • At 3 months of age, this infant is beyond the neonatal period and follows standard pediatric dosing of 50–75 mg/kg/day for non-meningeal infections 1, 2.

Intramuscular Administration Technique

Reconstitution for IM Injection

  • For a 500 mg vial: add 1.8 mL diluent to achieve 250 mg/mL concentration, or add 1.0 mL diluent for 350 mg/mL concentration 2.
  • For a 1 gram vial: add 3.6 mL diluent for 250 mg/mL, or 2.1 mL diluent for 350 mg/mL 2.

Injection Technique

  • Inject deep into a large muscle mass (e.g., vastus lateralis in infants) with aspiration to avoid intravascular injection 2.
  • Counsel caregivers that IM ceftriaxone is painful; consider lidocaine as diluent if not contraindicated 1, 3.

Indication-Specific Dosing Examples

Community-Acquired Pneumonia

  • Standard dose: 50–100 mg/kg/day, with the higher range (80–100 mg/kg/day) preferred for hospitalized infants or suspected resistant S. pneumoniae 1.
  • For this 7.3 kg infant: administer 365–730 mg/day (50–100 mg/kg), typically 500–600 mg IM once daily for moderate-to-severe pneumonia 1.

Sepsis or Bacteremia

  • Standard dose: 50–75 mg/kg/day once daily 1, 2.
  • For this 7.3 kg infant: administer 365–548 mg/day, rounded to 400–500 mg IM once daily 1.

Gonococcal Infections (Rare in This Age Group)

  • For disseminated gonococcal infection or bacteremia: 50 mg/kg/day (maximum 1 gram) for 7 days 1, 3.
  • For this 7.3 kg infant: administer 365 mg IM once daily for 7 days 1.

Treatment Duration

Standard Duration by Infection Type

  • Most serious infections: continue for at least 2 days after clinical improvement, with typical total duration of 4–14 days depending on infection severity 2.
  • Pneumonia: typically 7–10 days total 1, 4.
  • Meningitis: 10–14 days for most bacterial causes 1, 2.
  • Streptococcal infections: continue for at least 10 days to prevent rheumatic fever 2.

Common Pitfalls to Avoid

Underdosing Severe Infections

  • Do not use the lower end (50 mg/kg/day) for severe sepsis, meningitis, or pneumonia with consolidation—always use 75–100 mg/kg/day for life-threatening infections 1.

Neonatal Contraindications

  • Never administer ceftriaxone to hyperbilirubinemic neonates or those receiving calcium-containing IV solutions 1, 2.
  • At 3 months, this infant is beyond the high-risk neonatal period, but always check bilirubin if jaundice is present 2.

Inadequate Muscle Mass

  • In small infants, ensure injection into the vastus lateralis (anterolateral thigh), which has adequate muscle mass for IM administration 2.

Failure to Adjust for Meningitis

  • If meningitis is suspected or confirmed, immediately increase to 100 mg/kg/day (730 mg/day for this infant) 1, 2.

Practical Ordering Example

For a 3-month-old, 7.3 kg infant with community-acquired pneumonia:

  • Order: Ceftriaxone 500 mg IM once daily (approximately 68 mg/kg/day) for 7–10 days 1, 2.
  • Reconstitution: Use 500 mg vial with 1.8 mL sterile water to achieve 250 mg/mL; draw up 2 mL for 500 mg dose 2.
  • Administration: Inject deep into vastus lateralis muscle 2.

For the same infant with suspected meningitis:

  • Order: Ceftriaxone 365 mg IM every 12 hours (total 730 mg/day = 100 mg/kg/day) for 10–14 days 1, 2.

References

Guideline

Pediatric Dosing of Ceftriaxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ceftriaxone Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.